Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lichong shengsui yin
- Development stage
- Preclinical
- Administration
- Oral
01
Overview
Lichong Shengsui Yin is a **compound prescription Traditional Chinese Medicine (TCM) formula** primarily used in China for the treatment of ovarian cancer. It is derived from the classical TCM prescription "Li Chong Wan" and consists of multiple herbal and animal-derived ingredients, including Curcumae Rhizome, Sparganii Rhizome, Astragali Radix, Ginseng Radix et Rhizoma, Fritillariae Thunbergii Bulbus, Cervi Cornu Pantotrichum, Epimedii Folium, and Hirudo. Pharmacological studies demonstrate its ability to inhibit tumor cell growth and prolong survival in experimental ovarian cancer models. The anti-cancer activities are attributed to compounds such as germacrone, furandiene, β-elemene, calycosin-7-glucoside, ononin, epimedin B, icariin, ginsenoside Rc, astragaloside, ginsenoside Rd, and astragaloside II, although other active ingredients and synergistic effects are likely involved. Its mechanism involves multiple bioactive components and complex biological pathways, typical of multi-ingredient TCM prescriptions[1][3][4].
- Brand names
- lichong shengsui yin
- Other names
- LCSSY
Beyond the preview
Go deeper on lichong shengsui yin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lichong shengsui yin.